Viewing Study NCT06156332


Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2025-12-28 @ 10:18 PM
Study NCT ID: NCT06156332
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-12-05
First Post: 2023-11-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
Sponsor: Shanghai Changzheng Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module